Barclays Maintains an 'Overweight' on Universal Health Services (UHS) After Smart Acquisition of Ascend Health

June 5, 2012 2:17 PM EDT Send to a Friend
Get Alerts UHS Hot Sheet
Price: $67.02 +0.56%

Rating Summary:
    10 Buy, 6 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 0 | Down: 0 | New: 0
Trade UHS Now!
Barclays maintains an 'Overweight' on Universal Health Services (NYSE: UHS) price target of $55.00.

Analyst, Adam Feinstein, said, UHS announced that it reached a definitive agreement to acquire privately-held Ascend Health for $517 million, with the deal expected to close in 4Q12...We estimate that under an all-cash scenario, the transaction could be more than $0.30 accretive in 2013, representing upside of over 6% to our current 2013 EPS estimate. Hence, we believe this is a very good acquisition for UHS."

For an analyst ratings summary and ratings history on Universal Health Services click here. For more ratings news on Universal Health Services click here.

Shares of Universal Health Services closed at $37.89 yesterday, with a 52 week range of $31.35-$55.42.


Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here



You May Also Be Interested In


Related Categories

Analyst Comments, Analyst EPS View, Mergers and Acquisitions

Related Entities

Barclays

Add Your Comment